Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The roles and mechanisms of the lncRNA-miRNA axis in the progression of esophageal cancer: a narrative review. | J Thorac Dis | 2022 | 36524088 | PubTator, text mining | PubMed |
| Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model. | Toxicol Rep | 2022 | 36518412 | PubTator, text mining | PubMed |
| LncRNA weighted gene co-expression network analysis reveals novel biomarkers related to prostate cancer metastasis. | BMC Med Genomics | 2022 | 36514044 | PubTator, text mining | PubMed |
| A novel model based on immune-related genes for differentiating biliary atresia from other cholestatic diseases. | Pediatr Surg Int | 2022 | 36502440 | PubTator, text mining | PubMed |
| The Involvement of Long Non-Coding RNAs in Glutamine-Metabolic Reprogramming and Therapeutic Resistance in Cancer. | Int J Mol Sci | 2022 | 36499136 | PubTator, text mining | PubMed |
| Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation. | Cancers (Basel) | 2022 | 36497411 | PubTator, text mining | PubMed |
| Gene amplification-driven lncRNA SNHG6 promotes tumorigenesis via epigenetically suppressing p27 expression and regulating cell cycle in non-small cell lung cancer. | Cell Death Discov | 2022 | 36494339 | PubTator, text mining | PubMed |
| Oral Cancer Stem Cell-Derived Small Extracellular Vesicles Promote M2 Macrophage Polarization and Suppress CD4+ T-Cell Activity by Transferring UCA1 and Targeting LAMC2. | Stem Cells Int | 2022 | 36483681 | PubTator, text mining | PubMed |
| Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma. | Pharmgenomics Pers Med | 2022 | 36482943 | PubTator, text mining | PubMed |
| LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC. | J Exp Clin Cancer Res | 2022 | 36471363 | PubTator, text mining | PubMed |
| The LINC00852/miR-29a-3p/JARID2 axis regulates the proliferation and invasion of prostate cancer cell. | BMC Cancer | 2022 | 36471281 | PubTator, text mining | PubMed |
| Transcriptomic study reveals lncRNA-mediated downregulation of innate immune and inflammatory response in the SARS-CoV-2 vaccination breakthrough infections. | Front Immunol | 2022 | 36466827 | PubTator, text mining | PubMed |
| A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer. | Front Med (Lausanne) | 2022 | 36465903 | PubTator, text mining | PubMed |
| Extracellular RNA as a kind of communication molecule and emerging cancer biomarker. | Front Oncol | 2022 | 36465402 | PubTator, text mining | PubMed |
| The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines. | Sci Rep | 2022 | 36463254 | PubTator, text mining | PubMed |
| Recent miRNA Research in Asthma. | Curr Allergy Asthma Rep | 2022 | 36459329 | PubTator, text mining | PubMed |
| Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma. | Front Immunol | 2022 | 36457998 | PubTator, text mining | PubMed |
| The identification and preliminary study of lncRNA TUG1 and its related genes in hepatocellular carcinoma. | Arch Med Sci | 2022 | 36457956 | PubTator, text mining | PubMed |
| Characterization of Epithelial-Mesenchymal Transition Identifies a Gene Signature for Predicting Clinical Outcomes and Therapeutic Responses in Bladder Cancer. | Dis Markers | 2022 | 36457546 | PubTator, text mining | PubMed |
| RNA Modifications Meet Tumors. | Cancer Manag Res | 2022 | 36444355 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=29